Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Molecular Weight | 847.0 g/mol |
---|---|
Molecular Formula | C46H62N4O11 |
XLogP3 | 6.3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 5 |
Exact Mass | 846.44150881 g/mol |
Monoisotopic Mass | 846.44150881 g/mol |
Topological Polar Surface Area | 206 A^2 |
Heavy Atom Count | 61 |
Formal Charge | 0 |
Complexity | 1870 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Mycobutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 4 | |
---|---|
Drug Name | Rifabutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Lupin |
3 of 4 | |
---|---|
Drug Name | Rifabutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Lupin |
4 of 4 | |
---|---|
Drug Name | Mycobutin |
PubMed Health | Rifabutin (By mouth) |
Drug Classes | Antitubercular |
Drug Label | MYCOBUTIN Capsules contain the antimycobacterial agent rifabutin, which is a semisynthetic ansamycin antibiotic derived from rifamycin S. MYCOBUTIN Capsules for oral administration contain 150 mg of rifabutin, USP, per capsule, along with the inactiv... |
Active Ingredient | Rifabutin |
Dosage Form | Capsule |
Route | Oral |
Strength | 150mg |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-07-20
Pay. Date : 2018-05-08
DMF Number : 29047
Submission : 2015-01-22
Status : Active
Type : II
NDC Package Code : 17337-0059
Start Marketing Date : 2014-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35705
Submission : 2024-02-06
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19902
Submission : 2006-10-20
Status : Active
Type : II
Date of Issue : 2022-09-30
Valid Till : 2025-09-10
Written Confirmation Number : WC-0201
Address of the Firm :
Certificate Number : R0-CEP 2001-111 - Rev 01
Issue Date : 2005-03-10
Type : TSE
Substance Number : 1657
Status : Expired
Date of Issue : 2022-06-07
Valid Till : 2025-06-16
Written Confirmation Number : WC-0049
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35705
Submission : 2024-02-06
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19902
Submission : 2006-10-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-20
Pay. Date : 2018-05-08
DMF Number : 29047
Submission : 2015-01-22
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Rifabutin Pfizer Brand manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rifabutin Pfizer Brand, including repackagers and relabelers. The FDA regulates Rifabutin Pfizer Brand manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rifabutin Pfizer Brand API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rifabutin Pfizer Brand manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rifabutin Pfizer Brand supplier is an individual or a company that provides Rifabutin Pfizer Brand active pharmaceutical ingredient (API) or Rifabutin Pfizer Brand finished formulations upon request. The Rifabutin Pfizer Brand suppliers may include Rifabutin Pfizer Brand API manufacturers, exporters, distributors and traders.
click here to find a list of Rifabutin Pfizer Brand suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rifabutin Pfizer Brand DMF (Drug Master File) is a document detailing the whole manufacturing process of Rifabutin Pfizer Brand active pharmaceutical ingredient (API) in detail. Different forms of Rifabutin Pfizer Brand DMFs exist exist since differing nations have different regulations, such as Rifabutin Pfizer Brand USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rifabutin Pfizer Brand DMF submitted to regulatory agencies in the US is known as a USDMF. Rifabutin Pfizer Brand USDMF includes data on Rifabutin Pfizer Brand's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rifabutin Pfizer Brand USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rifabutin Pfizer Brand suppliers with USDMF on PharmaCompass.
A Rifabutin Pfizer Brand CEP of the European Pharmacopoeia monograph is often referred to as a Rifabutin Pfizer Brand Certificate of Suitability (COS). The purpose of a Rifabutin Pfizer Brand CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rifabutin Pfizer Brand EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rifabutin Pfizer Brand to their clients by showing that a Rifabutin Pfizer Brand CEP has been issued for it. The manufacturer submits a Rifabutin Pfizer Brand CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rifabutin Pfizer Brand CEP holder for the record. Additionally, the data presented in the Rifabutin Pfizer Brand CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rifabutin Pfizer Brand DMF.
A Rifabutin Pfizer Brand CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rifabutin Pfizer Brand CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rifabutin Pfizer Brand suppliers with CEP (COS) on PharmaCompass.
A Rifabutin Pfizer Brand written confirmation (Rifabutin Pfizer Brand WC) is an official document issued by a regulatory agency to a Rifabutin Pfizer Brand manufacturer, verifying that the manufacturing facility of a Rifabutin Pfizer Brand active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rifabutin Pfizer Brand APIs or Rifabutin Pfizer Brand finished pharmaceutical products to another nation, regulatory agencies frequently require a Rifabutin Pfizer Brand WC (written confirmation) as part of the regulatory process.
click here to find a list of Rifabutin Pfizer Brand suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rifabutin Pfizer Brand as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rifabutin Pfizer Brand API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rifabutin Pfizer Brand as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rifabutin Pfizer Brand and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rifabutin Pfizer Brand NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rifabutin Pfizer Brand suppliers with NDC on PharmaCompass.
Rifabutin Pfizer Brand Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rifabutin Pfizer Brand GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rifabutin Pfizer Brand GMP manufacturer or Rifabutin Pfizer Brand GMP API supplier for your needs.
A Rifabutin Pfizer Brand CoA (Certificate of Analysis) is a formal document that attests to Rifabutin Pfizer Brand's compliance with Rifabutin Pfizer Brand specifications and serves as a tool for batch-level quality control.
Rifabutin Pfizer Brand CoA mostly includes findings from lab analyses of a specific batch. For each Rifabutin Pfizer Brand CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rifabutin Pfizer Brand may be tested according to a variety of international standards, such as European Pharmacopoeia (Rifabutin Pfizer Brand EP), Rifabutin Pfizer Brand JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rifabutin Pfizer Brand USP).
LOOKING FOR A SUPPLIER?